Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > Net Income

Arbutus Biopharma Cp Net Income Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly Net Income from 2010 to 2018. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Arbutus Biopharma Cp Net Income for the quarter ending December 12, 2018 was $-18m a 4.70% decrease of -1m year over year
  • Arbutus Biopharma Cp Net Income for the last 12 months ending December 12, 2018 was $-57m a -45.74% increase of 26m year over year
  • Arbutus Biopharma Cp Annual Net Income for 2018 was $-57m a -47.81% increase of 27m from 2017
  • Arbutus Biopharma Cp Annual Net Income for 2017 was $-84m a -355.17% increase of 300m from 2016
  • Arbutus Biopharma Cp Annual Net Income for 2016 was $-384m a 83.67% decrease of -321m from 2015
Other Income Statement Metrics:
  • Arbutus Biopharma Cp EBITDA for the quarter ending December 12, 2018 was $-15m a -5.44% increase of 1m year over year
  • Arbutus Biopharma Cp Total Revenue for the quarter ending December 12, 2018 was $2m a 12.06% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS Net Income Data

12/2018$-18m
09/2018$-24m
06/2018$3m
03/2018$-17m
12/2017$-36m
09/2017$-12m
06/2017$-18m
03/2017$-19m
12/2016$-219m
09/2016$-20m

Annual ABUS Net Income Data

2018$-57m
2017$-84m
2016$-384m
2015$-63m
2014$-39m
2013$-14m
2012$30m
2011$-10m
2010$-12m
2009$-8m